Independent Director · GALECTIN THERAPEUTICS INC (GALT)

Kevin D. Freeman director compensation at Galectin (FY2024): $114K

Fiscal year 2024 director compensation for Kevin D. Freeman at GALECTIN THERAPEUTICS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed October 22, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Kevin D. Freeman’s full pay file as a PDF — free

More than this page: up to 10 years of Kevin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Kevin D. Freeman and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

GALECTIN THERAPEUTICS Director Compensation Table · all 4 fiscal years held
In US dollars, as GALECTIN THERAPEUTICS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$56,000$0$52,260$0$108,260
FY2024$56,000$0$58,000$0$114,000
FY2022$51,000$0$58,934$0$109,934
FY2021$51,000$0$171,800$0$222,800

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GALECTIN THERAPEUTICS INC DEF 14A filed October 22, 2025, accession 0001140361-25-038875, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GALECTIN THERAPEUTICS INC filed document, accession 0001140361-25-038875. Every figure is read from that document and cited to the page and table it appears in. Filed October 22, 2025.

Get the GALECTIN THERAPEUTICS Board Governance Report

$114,000 Kevin D. Freeman, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of October 22, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

GALECTIN THERAPEUTICS pays directors a $35,000 cash retainer.

Committees

FY2024 · as the proxy prints them

Audit · Compensation · Nominating/Governance

The rest of the GALECTIN THERAPEUTICS board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Benjamin S. Carson Sr., M.DDirector$98,000
Elissa J. Schwartz, Ph.DIndependent Director$101,500
Gilbert F. Amelio, Ph.DIndependent Director$113,500
Gilbert S. Omenn, M.D., Ph.DIndependent Director$108,000
Harold H. Shlevin, Ph.DIndependent Director$98,000
Joel LewisDirector—
Kary EldredIndependent Director$105,500
Marc Rubin, M.DIndependent Director$101,500
Richard A. ZordaniIndependent Director$113,000
Richard E. UihleinIndependent Director$98,000

The full GALECTIN THERAPEUTICS compensation record

free company brief

This page is one director within GALECTIN THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.

Order GALT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report